Stocks
ALPS Medical Breakthroughs ETFSBIO
AMEXHealthcareBiotechnology$49.81-0.74%
An exchange-traded fund that invests in small- and mid-cap biotechnology companies with drugs in Phase II or Phase III clinical trials. The portfolio is designed to provide exposure to firms approaching potential regulatory milestones, a stage often associated with significant valuation swings. Inve...
Market Cap: $133.3M52W Range: $22.33 – $54.79
Congressional Interest in ALPS Medical Breakthroughs ETF (SBIO)
1 member of Congress has disclosed 9 trades in ALPS Medical Breakthroughs ETF (SBIO), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
1
Buys
3
Sells
6
Who in Congress Is Trading SBIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-17 | Thomas R Carper | sell | $1K – $15K |
| 2023-02-15 | Thomas R Carper | sell | $1K – $15K |